疼痛治療薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Drugs for Pain Management Market Insights and Forecast to 2028

• レポートコード：QY2203B14333 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の疼痛治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に疼痛治療薬の世界市場のxxx％を占める「ジェネリックオピオイド」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の疼痛治療薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの疼痛治療薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの疼痛治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 疼痛治療薬のグローバル主要メーカーには、GSK、Pfizer、Grunenthal、Sanofi、Bayer、AstraZeneca、Eli Lilly、Endo、Merck、Yunnan Baiyao、Teikoku Seiyaku、Teva、J&J、Assertio Therapeutics、Allerganなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 疼痛治療薬市場は、種類と用途によって区分されます。世界の疼痛治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ジェネリックオピオイド、ブランドオピオイド、NSAIDs、その他 【用途別セグメント】 病院、ドラッグストア、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 疼痛治療薬製品概要 - 種類別市場（ジェネリックオピオイド、ブランドオピオイド、NSAIDs、その他） - 用途別市場（病院、ドラッグストア、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の疼痛治療薬販売量予測2017-2028 - 世界の疼痛治療薬売上予測2017-2028 - 疼痛治療薬の地域別販売量 - 疼痛治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別疼痛治療薬販売量 - 主要メーカー別疼痛治療薬売上 - 主要メーカー別疼痛治療薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ジェネリックオピオイド、ブランドオピオイド、NSAIDs、その他） - 疼痛治療薬の種類別販売量 - 疼痛治療薬の種類別売上 - 疼痛治療薬の種類別価格 ・用途別市場規模（病院、ドラッグストア、その他） - 疼痛治療薬の用途別販売量 - 疼痛治療薬の用途別売上 - 疼痛治療薬の用途別価格 ・北米市場 - 北米の疼痛治療薬市場規模（種類別、用途別） - 主要国別の疼痛治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの疼痛治療薬市場規模（種類別、用途別） - 主要国別の疼痛治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の疼痛治療薬市場規模（種類別、用途別） - 主要国別の疼痛治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の疼痛治療薬市場規模（種類別、用途別） - 主要国別の疼痛治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの疼痛治療薬市場規模（種類別、用途別） - 主要国別の疼痛治療薬市場規模（トルコ、サウジアラビア） ・企業情報 GSK、Pfizer、Grunenthal、Sanofi、Bayer、AstraZeneca、Eli Lilly、Endo、Merck、Yunnan Baiyao、Teikoku Seiyaku、Teva、J&J、Assertio Therapeutics、Allergan ・産業チェーン及び販売チャネル分析 - 疼痛治療薬の産業チェーン分析 - 疼痛治療薬の原材料 - 疼痛治療薬の生産プロセス - 疼痛治療薬の販売及びマーケティング - 疼痛治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 疼痛治療薬の産業動向 - 疼痛治療薬のマーケットドライバー - 疼痛治療薬の課題 - 疼痛治療薬の阻害要因 ・主な調査結果

Pain is complex, so there are many treatment options — medications, therapies, and mind-body techniques.
Market Analysis and Insights: Global Drugs for Pain Management Market
The global Drugs for Pain Management market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Generic Opioid accounting for % of the Drugs for Pain Management global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Drugs for Pain Management market size is valued at US$ million in 2021, while the North America and Europe Drugs for Pain Management are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Drugs for Pain Management landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drugs for Pain Management market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drugs for Pain Management market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drugs for Pain Management market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drugs for Pain Management market.
Global Drugs for Pain Management Scope and Market Size
Drugs for Pain Management market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Drugs for Pain Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Generic Opioid
Branded Opioids
NSAIDs
Others
Segment by Application
Hospitals
Drugstores
Others
By Company
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Pain Management Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Generic Opioid
1.2.3 Branded Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drugs for Pain Management Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Pain Management Market Perspective (2017-2028)
2.2 Drugs for Pain Management Growth Trends by Region
2.2.1 Drugs for Pain Management Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drugs for Pain Management Historic Market Size by Region (2017-2022)
2.2.3 Drugs for Pain Management Forecasted Market Size by Region (2023-2028)
2.3 Drugs for Pain Management Market Dynamics
2.3.1 Drugs for Pain Management Industry Trends
2.3.2 Drugs for Pain Management Market Drivers
2.3.3 Drugs for Pain Management Market Challenges
2.3.4 Drugs for Pain Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Pain Management Players by Revenue
3.1.1 Global Top Drugs for Pain Management Players by Revenue (2017-2022)
3.1.2 Global Drugs for Pain Management Revenue Market Share by Players (2017-2022)
3.2 Global Drugs for Pain Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Pain Management Revenue
3.4 Global Drugs for Pain Management Market Concentration Ratio
3.4.1 Global Drugs for Pain Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Pain Management Revenue in 2021
3.5 Drugs for Pain Management Key Players Head office and Area Served
3.6 Key Players Drugs for Pain Management Product Solution and Service
3.7 Date of Enter into Drugs for Pain Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Pain Management Breakdown Data by Type
4.1 Global Drugs for Pain Management Historic Market Size by Type (2017-2022)
4.2 Global Drugs for Pain Management Forecasted Market Size by Type (2023-2028)
5 Drugs for Pain Management Breakdown Data by Application
5.1 Global Drugs for Pain Management Historic Market Size by Application (2017-2022)
5.2 Global Drugs for Pain Management Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drugs for Pain Management Market Size (2017-2028)
6.2 North America Drugs for Pain Management Market Size by Type
6.2.1 North America Drugs for Pain Management Market Size by Type (2017-2022)
6.2.2 North America Drugs for Pain Management Market Size by Type (2023-2028)
6.2.3 North America Drugs for Pain Management Market Share by Type (2017-2028)
6.3 North America Drugs for Pain Management Market Size by Application
6.3.1 North America Drugs for Pain Management Market Size by Application (2017-2022)
6.3.2 North America Drugs for Pain Management Market Size by Application (2023-2028)
6.3.3 North America Drugs for Pain Management Market Share by Application (2017-2028)
6.4 North America Drugs for Pain Management Market Size by Country
6.4.1 North America Drugs for Pain Management Market Size by Country (2017-2022)
6.4.2 North America Drugs for Pain Management Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Drugs for Pain Management Market Size (2017-2028)
7.2 Europe Drugs for Pain Management Market Size by Type
7.2.1 Europe Drugs for Pain Management Market Size by Type (2017-2022)
7.2.2 Europe Drugs for Pain Management Market Size by Type (2023-2028)
7.2.3 Europe Drugs for Pain Management Market Share by Type (2017-2028)
7.3 Europe Drugs for Pain Management Market Size by Application
7.3.1 Europe Drugs for Pain Management Market Size by Application (2017-2022)
7.3.2 Europe Drugs for Pain Management Market Size by Application (2023-2028)
7.3.3 Europe Drugs for Pain Management Market Share by Application (2017-2028)
7.4 Europe Drugs for Pain Management Market Size by Country
7.4.1 Europe Drugs for Pain Management Market Size by Country (2017-2022)
7.4.2 Europe Drugs for Pain Management Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Pain Management Market Size (2017-2028)
8.2 Asia-Pacific Drugs for Pain Management Market Size by Type
8.2.1 Asia-Pacific Drugs for Pain Management Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Drugs for Pain Management Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Drugs for Pain Management Market Share by Type (2017-2028)
8.3 Asia-Pacific Drugs for Pain Management Market Size by Application
8.3.1 Asia-Pacific Drugs for Pain Management Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Drugs for Pain Management Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Drugs for Pain Management Market Share by Application (2017-2028)
8.4 Asia-Pacific Drugs for Pain Management Market Size by Region
8.4.1 Asia-Pacific Drugs for Pain Management Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Drugs for Pain Management Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drugs for Pain Management Market Size (2017-2028)
9.2 Latin America Drugs for Pain Management Market Size by Type
9.2.1 Latin America Drugs for Pain Management Market Size by Type (2017-2022)
9.2.2 Latin America Drugs for Pain Management Market Size by Type (2023-2028)
9.2.3 Latin America Drugs for Pain Management Market Share by Type (2017-2028)
9.3 Latin America Drugs for Pain Management Market Size by Application
9.3.1 Latin America Drugs for Pain Management Market Size by Application (2017-2022)
9.3.2 Latin America Drugs for Pain Management Market Size by Application (2023-2028)
9.3.3 Latin America Drugs for Pain Management Market Share by Application (2017-2028)
9.4 Latin America Drugs for Pain Management Market Size by Country
9.4.1 Latin America Drugs for Pain Management Market Size by Country (2017-2022)
9.4.2 Latin America Drugs for Pain Management Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Pain Management Market Size (2017-2028)
10.2 Middle East & Africa Drugs for Pain Management Market Size by Type
10.2.1 Middle East & Africa Drugs for Pain Management Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Drugs for Pain Management Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Drugs for Pain Management Market Share by Type (2017-2028)
10.3 Middle East & Africa Drugs for Pain Management Market Size by Application
10.3.1 Middle East & Africa Drugs for Pain Management Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Drugs for Pain Management Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Drugs for Pain Management Market Share by Application (2017-2028)
10.4 Middle East & Africa Drugs for Pain Management Market Size by Country
10.4.1 Middle East & Africa Drugs for Pain Management Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Drugs for Pain Management Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Drugs for Pain Management Introduction
11.1.4 GSK Revenue in Drugs for Pain Management Business (2017-2022)
11.1.5 GSK Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drugs for Pain Management Introduction
11.2.4 Pfizer Revenue in Drugs for Pain Management Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Grunenthal
11.3.1 Grunenthal Company Details
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal Drugs for Pain Management Introduction
11.3.4 Grunenthal Revenue in Drugs for Pain Management Business (2017-2022)
11.3.5 Grunenthal Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Drugs for Pain Management Introduction
11.4.4 Sanofi Revenue in Drugs for Pain Management Business (2017-2022)
11.4.5 Sanofi Recent Developments
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Drugs for Pain Management Introduction
11.5.4 Bayer Revenue in Drugs for Pain Management Business (2017-2022)
11.5.5 Bayer Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Drugs for Pain Management Introduction
11.6.4 AstraZeneca Revenue in Drugs for Pain Management Business (2017-2022)
11.6.5 AstraZeneca Recent Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Drugs for Pain Management Introduction
11.7.4 Eli Lilly Revenue in Drugs for Pain Management Business (2017-2022)
11.7.5 Eli Lilly Recent Developments
11.8 Endo
11.8.1 Endo Company Details
11.8.2 Endo Business Overview
11.8.3 Endo Drugs for Pain Management Introduction
11.8.4 Endo Revenue in Drugs for Pain Management Business (2017-2022)
11.8.5 Endo Recent Developments
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Drugs for Pain Management Introduction
11.9.4 Merck Revenue in Drugs for Pain Management Business (2017-2022)
11.9.5 Merck Recent Developments
11.10 Yunnan Baiyao
11.10.1 Yunnan Baiyao Company Details
11.10.2 Yunnan Baiyao Business Overview
11.10.3 Yunnan Baiyao Drugs for Pain Management Introduction
11.10.4 Yunnan Baiyao Revenue in Drugs for Pain Management Business (2017-2022)
11.10.5 Yunnan Baiyao Recent Developments
11.11 Teikoku Seiyaku
11.11.1 Teikoku Seiyaku Company Details
11.11.2 Teikoku Seiyaku Business Overview
11.11.3 Teikoku Seiyaku Drugs for Pain Management Introduction
11.11.4 Teikoku Seiyaku Revenue in Drugs for Pain Management Business (2017-2022)
11.11.5 Teikoku Seiyaku Recent Developments
11.12 Teva
11.12.1 Teva Company Details
11.12.2 Teva Business Overview
11.12.3 Teva Drugs for Pain Management Introduction
11.12.4 Teva Revenue in Drugs for Pain Management Business (2017-2022)
11.12.5 Teva Recent Developments
11.13 J&J
11.13.1 J&J Company Details
11.13.2 J&J Business Overview
11.13.3 J&J Drugs for Pain Management Introduction
11.13.4 J&J Revenue in Drugs for Pain Management Business (2017-2022)
11.13.5 J&J Recent Developments
11.14 Assertio Therapeutics
11.14.1 Assertio Therapeutics Company Details
11.14.2 Assertio Therapeutics Business Overview
11.14.3 Assertio Therapeutics Drugs for Pain Management Introduction
11.14.4 Assertio Therapeutics Revenue in Drugs for Pain Management Business (2017-2022)
11.14.5 Assertio Therapeutics Recent Developments
11.15 Allergan
11.15.1 Allergan Company Details
11.15.2 Allergan Business Overview
11.15.3 Allergan Drugs for Pain Management Introduction
11.15.4 Allergan Revenue in Drugs for Pain Management Business (2017-2022)
11.15.5 Allergan Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Drugs for Pain Management Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Generic Opioid
Table 3. Key Players of Branded Opioids
Table 4. Key Players of NSAIDs
Table 5. Key Players of Others
Table 6. Global Drugs for Pain Management Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Drugs for Pain Management Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Drugs for Pain Management Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Drugs for Pain Management Market Share by Region (2017-2022)
Table 10. Global Drugs for Pain Management Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Drugs for Pain Management Market Share by Region (2023-2028)
Table 12. Drugs for Pain Management Market Trends
Table 13. Drugs for Pain Management Market Drivers
Table 14. Drugs for Pain Management Market Challenges
Table 15. Drugs for Pain Management Market Restraints
Table 16. Global Drugs for Pain Management Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Drugs for Pain Management Revenue Share by Players (2017-2022)
Table 18. Global Top Drugs for Pain Management by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Pain Management as of 2021)
Table 19. Ranking of Global Top Drugs for Pain Management Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Drugs for Pain Management Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Drugs for Pain Management Product Solution and Service
Table 23. Date of Enter into Drugs for Pain Management Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drugs for Pain Management Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Drugs for Pain Management Revenue Market Share by Type (2017-2022)
Table 27. Global Drugs for Pain Management Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Drugs for Pain Management Revenue Market Share by Type (2023-2028)
Table 29. Global Drugs for Pain Management Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Drugs for Pain Management Revenue Share by Application (2017-2022)
Table 31. Global Drugs for Pain Management Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Drugs for Pain Management Revenue Share by Application (2023-2028)
Table 33. North America Drugs for Pain Management Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Drugs for Pain Management Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Drugs for Pain Management Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Drugs for Pain Management Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Drugs for Pain Management Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Drugs for Pain Management Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Drugs for Pain Management Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Drugs for Pain Management Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Drugs for Pain Management Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Drugs for Pain Management Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Drugs for Pain Management Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Drugs for Pain Management Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Drugs for Pain Management Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Drugs for Pain Management Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Drugs for Pain Management Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Drugs for Pain Management Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Drugs for Pain Management Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Drugs for Pain Management Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Drugs for Pain Management Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Drugs for Pain Management Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Drugs for Pain Management Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Drugs for Pain Management Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Drugs for Pain Management Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Drugs for Pain Management Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Drugs for Pain Management Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Drugs for Pain Management Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Drugs for Pain Management Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Drugs for Pain Management Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Drugs for Pain Management Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Drugs for Pain Management Market Size by Country (2023-2028) & (US$ Million)
Table 63. GSK Company Details
Table 64. GSK Business Overview
Table 65. GSK Drugs for Pain Management Product
Table 66. GSK Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 67. GSK Recent Developments
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Drugs for Pain Management Product
Table 71. Pfizer Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 72. Pfizer Recent Developments
Table 73. Grunenthal Company Details
Table 74. Grunenthal Business Overview
Table 75. Grunenthal Drugs for Pain Management Product
Table 76. Grunenthal Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 77. Grunenthal Recent Developments
Table 78. Sanofi Company Details
Table 79. Sanofi Business Overview
Table 80. Sanofi Drugs for Pain Management Product
Table 81. Sanofi Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 82. Sanofi Recent Developments
Table 83. Bayer Company Details
Table 84. Bayer Business Overview
Table 85. Bayer Drugs for Pain Management Product
Table 86. Bayer Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 87. Bayer Recent Developments
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Drugs for Pain Management Product
Table 91. AstraZeneca Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 92. AstraZeneca Recent Developments
Table 93. Eli Lilly Company Details
Table 94. Eli Lilly Business Overview
Table 95. Eli Lilly Drugs for Pain Management Product
Table 96. Eli Lilly Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 97. Eli Lilly Recent Developments
Table 98. Endo Company Details
Table 99. Endo Business Overview
Table 100. Endo Drugs for Pain Management Product
Table 101. Endo Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 102. Endo Recent Developments
Table 103. Merck Company Details
Table 104. Merck Business Overview
Table 105. Merck Drugs for Pain Management Product
Table 106. Merck Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 107. Merck Recent Developments
Table 108. Yunnan Baiyao Company Details
Table 109. Yunnan Baiyao Business Overview
Table 110. Yunnan Baiyao Drugs for Pain Management Product
Table 111. Yunnan Baiyao Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 112. Yunnan Baiyao Recent Developments
Table 113. Teikoku Seiyaku Company Details
Table 114. Teikoku Seiyaku Business Overview
Table 115. Teikoku Seiyaku Drugs for Pain Management Product
Table 116. Teikoku Seiyaku Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 117. Teikoku Seiyaku Recent Developments
Table 118. Teva Company Details
Table 119. Teva Business Overview
Table 120. Teva Drugs for Pain Management Product
Table 121. Teva Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 122. Teva Recent Developments
Table 123. J&J Company Details
Table 124. J&J Business Overview
Table 125. J&J Drugs for Pain Management Product
Table 126. J&J Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 127. J&J Recent Developments
Table 128. Assertio Therapeutics Company Details
Table 129. Assertio Therapeutics Business Overview
Table 130. Assertio Therapeutics Drugs for Pain Management Product
Table 131. Assertio Therapeutics Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 132. Assertio Therapeutics Recent Developments
Table 133. Allergan Company Details
Table 134. Allergan Business Overview
Table 135. Allergan Drugs for Pain Management Product
Table 136. Allergan Revenue in Drugs for Pain Management Business (2017-2022) & (US$ Million)
Table 137. Allergan Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Pain Management Market Share by Type: 2021 VS 2028
Figure 2. Generic Opioid Features
Figure 3. Branded Opioids Features
Figure 4. NSAIDs Features
Figure 5. Others Features
Figure 6. Global Drugs for Pain Management Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Drugstores Case Studies
Figure 9. Others Case Studies
Figure 10. Drugs for Pain Management Report Years Considered
Figure 11. Global Drugs for Pain Management Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Drugs for Pain Management Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Drugs for Pain Management Market Share by Region: 2021 VS 2028
Figure 14. Global Drugs for Pain Management Market Share by Players in 2021
Figure 15. Global Top Drugs for Pain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Pain Management as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Drugs for Pain Management Revenue in 2021
Figure 17. North America Drugs for Pain Management Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Drugs for Pain Management Market Size Market Share by Type (2017-2028)
Figure 19. North America Drugs for Pain Management Market Size Market Share by Application (2017-2028)
Figure 20. North America Drugs for Pain Management Market Size Share by Country (2017-2028)
Figure 21. United States Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Drugs for Pain Management Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Drugs for Pain Management Market Size Market Share by Type (2017-2028)
Figure 25. Europe Drugs for Pain Management Market Size Market Share by Application (2017-2028)
Figure 26. Europe Drugs for Pain Management Market Size Share by Country (2017-2028)
Figure 27. Germany Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Drugs for Pain Management Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Drugs for Pain Management Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Drugs for Pain Management Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Drugs for Pain Management Market Size Share by Region (2017-2028)
Figure 37. China Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Drugs for Pain Management Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Drugs for Pain Management Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Drugs for Pain Management Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Drugs for Pain Management Market Size Share by Country (2017-2028)
Figure 47. Mexico Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Drugs for Pain Management Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Drugs for Pain Management Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Drugs for Pain Management Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Drugs for Pain Management Market Size Share by Country (2017-2028)
Figure 53. Turkey Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Drugs for Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. GSK Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 58. Grunenthal Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 59. Sanofi Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 60. Bayer Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 61. AstraZeneca Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 62. Eli Lilly Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 63. Endo Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 64. Merck Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 65. Yunnan Baiyao Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 66. Teikoku Seiyaku Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 67. Teva Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 68. J&J Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 69. Assertio Therapeutics Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 70. Allergan Revenue Growth Rate in Drugs for Pain Management Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---